Inhibrx Biosciences INBX Stock
Inhibrx Biosciences Price Chart
Inhibrx Biosciences INBX Financial and Trading Overview
| Inhibrx Biosciences stock price | 95.22 USD |
| Previous Close | 104.01 USD |
| Open | 104 USD |
| Bid | 74.9 USD x 200 |
| Ask | 125.44 USD x 200 |
| Day's Range | 96.75 - 105.09 USD |
| 52 Week Range | 12.72 - 155.29 USD |
| Volume | 261.25K USD |
| Avg. Volume | 405.62K USD |
| Market Cap | 1.46B USD |
| Beta (5Y Monthly) | 3.889 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.39 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 277.5 USD |
INBX Valuation Measures
| Enterprise Value | 1.55B USD |
| Trailing P/E | N/A |
| Forward P/E | -35.587814 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1120.54 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1188.609 |
| Enterprise Value/EBITDA | -12.801 |
Trading Information
Inhibrx Biosciences Stock Price History
| Beta (5Y Monthly) | 3.889 |
| 52-Week Change | 702.54% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 155.29 USD |
| 52 Week Low | 12.72 USD |
| 50-Day Moving Average | 96.56 USD |
| 200-Day Moving Average | 70.36 USD |
INBX Share Statistics
| Avg. Volume (3 month) | 405.62K USD |
| Avg. Daily Volume (10-Days) | 349.47K USD |
| Shares Outstanding | 14.67M |
| Float | 7.86M |
| Short Ratio | 4.37 |
| % Held by Insiders | 23.15% |
| % Held by Institutions | 82.99% |
| Shares Short | 2.93M |
| Short % of Float | 26.71% |
| Short % of Shares Outstanding | 19.98% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -9465.46% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.055% |
| Return on Equity (ttm) | -354.68% |
Income Statement
| Revenue (ttm) | 1.3M USD |
| Revenue Per Share (ttm) | 0.08 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -100068000 USD |
| EBITDA | -120706000 USD |
| Net Income Avi to Common (ttm) | -130185000 USD |
| Diluted EPS (ttm) | -8.39 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 161.66M USD |
| Total Cash Per Share (mrq) | 11.02 USD |
| Total Debt (mrq) | 180.9M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.463 |
| Book Value Per Share (mrq) | -1.44 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -131925000 USD |
| Levered Free Cash Flow (ttm) | -89107872 USD |
Profile of Inhibrx Biosciences
| Country | United States |
| State | CA |
| City | La Jolla |
| Address | 11025 North Torrey Pines Road |
| ZIP | 92037 |
| Phone | 858 795 4220 |
| Website | https://inhibrx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 109 |
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Q&A For Inhibrx Biosciences Stock
What is a current INBX stock price?
Inhibrx Biosciences INBX stock price today per share is 95.22 USD.
How to purchase Inhibrx Biosciences stock?
You can buy INBX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Inhibrx Biosciences?
The stock symbol or ticker of Inhibrx Biosciences is INBX.
Which industry does the Inhibrx Biosciences company belong to?
The Inhibrx Biosciences industry is Biotechnology.
How many shares does Inhibrx Biosciences have in circulation?
The max supply of Inhibrx Biosciences shares is 14.67M.
What is Inhibrx Biosciences Price to Earnings Ratio (PE Ratio)?
Inhibrx Biosciences PE Ratio is now.
What was Inhibrx Biosciences earnings per share over the trailing 12 months (TTM)?
Inhibrx Biosciences EPS is -8.39 USD over the trailing 12 months.
Which sector does the Inhibrx Biosciences company belong to?
The Inhibrx Biosciences sector is Healthcare.
Inhibrx Biosciences INBX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| US Tech Biotechnology NBI | 5807.22 USD — |
+1.87
|
— — | 5685.34 USD — | 5809.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}